Table 3.
Intraoperative and postoperative outcomes
| Outcomes | Placebo group | TXA group |
|---|---|---|
| Total blood loss (mL) | 807.30 ± 389.75 | 618.91 ± 282.72 |
| Hidden blood loss (mL) | 619.47 ± 311.93 | 438.86 ± 265.61 |
| Intraoperative blood loss (mL) | 136.09 ± 86.19 | 103.60 ± 75.75 |
| Transfusion rate (n) | 456 (n = 1118) | 232 (n = 1112) |
| Postoperative Hb Level day 1 (g/L) | 95.55 ± 28.17 | 104.42 ± 13.72 |
| Postoperative Hb Level day 3 (g/L) | 84.30 ± 17.79 | 91.46 ± 14.74 |
| Incidence of postoperative DVT (n) | 22 (n = 753) | 27 (n = 753) |
| Incidence of postoperative PE (n) | 28 (n = 830) | 34 (n = 831) |
| Length of hospital stay (days) | 11.19 ± 5.80 | 10.13 ± 4.11 |
| Operation time (minutes) | 80.30 ± 32.07 | 79.99 ± 30.96 |
DVT Deep vein thrombosis, Hb Hemoglobin, PE Pulmonary embolism